UCB, a global biopharmaceutical company, today announced positive topline data from the BE BOLD trial assessing BIMZELX® (bimekizumab) versus SKYRIZI® (risankizumab) in adults with active psoriatic ...

Bristol Myers Squibb Company on Friday won U.S. approval for its oral drug Sotyktu to treat adults with active psoriatic arthritis. The decision gives patients another option for joint and skin ...

In clinical trials, more than half of all patients treated with deucravacitinib achieved at least 20% improvement in American College of Rheumatology response criteria.

Rigorous field testing confirms WaterCube exceeds production expectations and meets the U.S. Army’s strict TB MED-577 ...

U.S. FDA Approves Bristol Myers Squibb’s Sotyktu® (deucravacitinib) for the Treatment of Adults with Active Psoriatic Arthritis ...

Background Psoriatic disease has a complex effect on bone metabolism, resulting in both pathological bone formation and bone resorption. However, microstructural changes in cortical and trabecular ...

More than 1.7 million people currently receive either £73.90 or £110.40 each week through Attendance Allowance, or Pension Age Disability Payment in Scotland.

A 91-year-old man with a history of bladder carcinoma and left total knee arthroplasty was evaluated because of left knee pain. A culture of synovial fluid showed no growth. A diagnosis was made.

Turmeric is a flavorful spice that contains natural painkillers, such as curcumin, which has been used to manage arthritis, fibromyalgia, and muscle and nerve pain. You can add turmeric to your ...

Renée Fabian is Lead Editor for Pet Health at Forbes Advisor. She has over 10 years experience as a journalist and editor covering pet and human health topics ...

Health workers in developing countries know that isolating tuberculosis patients is an outdated and potentially harmful practice, but lack the resources to move away from it. By Stephanie Nolen ...